PPM1D and cancer: The aim is to propose a treatment that would reduce the levels or activity of Wip1, Mdm2, PI3K in cancer cells to make them more sensitive to radiotherapy, and to devise optimal drug and irradiation protocols that would leverage the impact of inhibitors by synchronizing their administration with the induced DNA damage.